Cited In for PMID: 34516970

Year	Number of Results
2021	1
2022	3
2023	9
2024	0

1

P2X7 receptor blockade reduces tau induced toxicity, therapeutic implications in tauopathies.

Di Lauro C, Bianchi C, Sebastián-Serrano Á, Soria-Tobar L, Alvarez-Castelao B, Nicke A, Díaz-Hernández M. Di Lauro C, et al. Prog Neurobiol. 2022 Jan;208:102173. doi: 10.1016/j.pneurobio.2021.102173. Epub 2021 Sep 10. Prog Neurobiol. 2022. PMID: 34516970 Free article.

2

Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation.

Kiaie SH, Hatami Z, Nasr MS, Pazooki P, Hemmati S, Baradaran B, Valizadeh H. Kiaie SH, et al. Purinergic Signal. 2023 Oct 16. doi: 10.1007/s11302-023-09966-7. Online ahead of print. Purinergic Signal. 2023. PMID: 37843749 Review.

3

P2X₇R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes.

Beltran-Lobo P, Hughes MM, Troakes C, Croft CL, Rupawala H, Jutzi D, Ruepp MD, Jimenez-Sanchez M, Perkinton MS, Kassiou M, Golde TE, Hanger DP, Verkhratsky A, Perez-Nievas BG, Noble W. Beltran-Lobo P, et al. Brain Behav Immun. 2023 Nov;114:414-429. doi: 10.1016/j.bbi.2023.09.011. Epub 2023 Sep 15. Brain Behav Immun. 2023. PMID: 37716378 Free PMC article.

4

Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody.

Esparza TJ, Su S, Francescutti CM, Rodionova E, Kim JH, Brody DL. Esparza TJ, et al. Fluids Barriers CNS. 2023 Aug 24;20(1):64. doi: 10.1186/s12987-023-00462-z. Fluids Barriers CNS. 2023. PMID: 37620930 Free PMC article.

5

The P2X7 Receptor, a Multifaceted Receptor in Alzheimer's Disease.

Ronning KE, Déchelle-Marquet PA, Che Y, Guillonneau X, Sennlaub F, Delarasse C. Ronning KE, et al. Int J Mol Sci. 2023 Jul 21;24(14):11747. doi: 10.3390/ijms241411747. Int J Mol Sci. 2023. PMID: 37511507 Free PMC article. Review.

6

TNAP and P2X7R: New Plasma Biomarkers for Alzheimer's Disease.

Aivar P, Bianchi C, Di Lauro C, Soria-Tobar L, Alvarez-Castelao B, Calero M, Medina M, Diaz-Hernandez M. Aivar P, et al. Int J Mol Sci. 2023 Jun 30;24(13):10897. doi: 10.3390/ijms241310897. Int J Mol Sci. 2023. PMID: 37446074 Free PMC article.

7

P2X₇ Receptor and Extracellular Vesicle Release.

Golia MT, Gabrielli M, Verderio C. Golia MT, et al. Int J Mol Sci. 2023 Jun 6;24(12):9805. doi: 10.3390/ijms24129805. Int J Mol Sci. 2023. PMID: 37372953 Free PMC article. Review.

8

Enhanced in Vivo Blood Brain Barrier Transcytosis of Macromolecular Cargo Using an Engineered pH-sensitive Mouse Transferrin Receptor Binding Nanobody.

Esparza TJ, Su S, Francescutti CM, Rodionova E, Kim JH, Brody DL. Esparza TJ, et al. bioRxiv [Preprint]. 2023 Apr 27:2023.04.26.538462. doi: 10.1101/2023.04.26.538462. bioRxiv. 2023. PMID: 37333358 Free PMC article. Updated. Preprint.

9

P2X7 receptor inhibition ameliorates ubiquitin-proteasome system dysfunction associated with Alzheimer's disease.

Bianchi C, Alvarez-Castelao B, Sebastián-Serrano Á, Di Lauro C, Soria-Tobar L, Nicke A, Engel T, Díaz-Hernández M. Bianchi C, et al. Alzheimers Res Ther. 2023 Jun 7;15(1):105. doi: 10.1186/s13195-023-01258-x. Alzheimers Res Ther. 2023. PMID: 37287063 Free PMC article.

10

Astrocyte adaptation in Alzheimer's disease: a focus on astrocytic P2X7R.

Beltran-Lobo P, Reid MJ, Jimenez-Sanchez M, Verkhratsky A, Perez-Nievas BG, Noble W. Beltran-Lobo P, et al. Essays Biochem. 2023 Mar 3;67(1):119-130. doi: 10.1042/EBC20220079. Essays Biochem. 2023. PMID: 36449279 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year